Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence

Drug Alcohol Depend. 2023 Mar 1:244:109766. doi: 10.1016/j.drugalcdep.2023.109766. Epub 2023 Jan 8.

Abstract

Background: The hyperdirect pathway - a circuit involved in executing inhibitory control (IC) - is dysregulated among individuals with nicotine dependence. The right inferior frontal gyrus (rIFG), a cortical input to the hyperdirect circuit, has been shown to be functionally and structurally altered among nicotine-dependent people who smoke. The rIFG is composed of 3 cytoarchitecturally distinct subregions: The pars opercularis, pars triangularis, and pars orbitalis. The present study assessed the relationship between rIFG subregion morphometry and inhibitory control among individuals with nicotine dependence.

Methods: Behavioral and magnetic resonance brain imaging (MRI) data from 127 nicotine-dependent adults who smoke (MFTND = 5.4, ± 1.9; MCPD = 18.3, ± 7.0; Myears = 25.04, ± 11.97) (Mage = 42.9, ± 11.1) were assessed. Brain morphometry was assessed from T1-weighted MRIs using Freesurfer. IC was assessed with a response-inhibition Go/Go/No-Go (GGNG) task and a smoking relapse analog task (SRT).

Results and conclusions: Vertex-wise analyses revealed that GGNG task scores were positively associated with cortical thickness and volume in the right pars triangularis (cluster-wise p = 0.006, 90% CI = 0.003 - 0.009; cluster-wise p = 0.040, 90% CI = 0.032 - 0.048), and the ability to inhibit ad lib smoking during the SRT was positively associated with cortical thickness in the right pars orbitalis (cluster-wise p = 0.011, 90% CI = 0.007 - 0.015). Our results indicate that cortical thickness of distinct rIFG subregions may serve as biomarkers for unique forms of IC deficits.

Keywords: addiction; inhibitory control; magnetic resonance imaging; nicotine; smoking cessation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Brain / physiology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Nicotine*
  • Prefrontal Cortex / pathology
  • Tobacco Use Disorder*

Substances

  • Nicotine